{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T21:56:00Z","timestamp":1722290160104},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2018,12,31]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Presenilin-1 (PSEN-1) is a component of the \u03b3-secretase complex involved in\n\u03b2-amyloid Precursor Protein (A\u03b2PP) processing. Usually, Alzheimer\u2019s disease (AD)-linked mutations in\nthe PSEN-1 gene lead to the early onset and increase the production of the aggregation-prone peptide\nA\u03b242. However, the PSEN-1 E318G variant has an unclear pathogenic role and is recently reported as a\ngenetic risk factor for AD. In particular, E318G variant presence correlated with increased cerebrospinal\nfluid (CSF) levels of Total Tau (t-tau) and Phosphorylated Tau (p-tau).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> We describe a large Italian family, which we followed from January 2003 to January 2018,\nwith the late-onset AD and the E318G variant, with the aim of assessing E318G-associated CSF or\nplasma biochemical changes in biomarkers of dementia.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title \/>\n<jats:p>\nMethod: CSF A\u03b242, t-tau and p-tau, plasma A\u03b242 and A\u03b240 were assessed by ELISA tests, while CSF\namyloid peptides profile was investigated by mass spectrometry.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>\n We did not find any changes in CSF biochemical markers (A\u03b242, t-tau, p-tau and amyloid peptides)\nof asymptomatic E318G carriers in 2010 and 2012, but plasma A\u03b240 was increased at the same\ntimes. From 2003 to 2018, no asymptomatic E318G carrier developed AD.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>\n Our follow-up of this family may help elucidate E318G\u2019s role in AD and globally points to\na null effect of this variant.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567205015666181031150345","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T07:53:13Z","timestamp":1541058793000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer\u2019s disease in a Family with Late-onset Dementia"],"prefix":"10.2174","volume":"16","author":[{"given":"Vladimiro","family":"Artuso","sequence":"first","affiliation":[{"name":"ULSS 3 Serenissima, via Don Tosatto 147 - 30174 Mestre, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Benussi","sequence":"additional","affiliation":[{"name":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Ghidoni","sequence":"additional","affiliation":[{"name":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Moradi-Bachiller","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Fusco","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Curtolo","sequence":"additional","affiliation":[{"name":"ULSS 2 Marca Trevigiana, Ca' Foncello Hospital, Piazzale Ospedale, 1, 31100 Treviso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Roiter","sequence":"additional","affiliation":[{"name":"ULSS 2 Marca Trevigiana, Ca' Foncello Hospital, Piazzale Ospedale, 1, 31100 Treviso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Forloni","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Albani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via La Masa 19, 20156, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"Goate A.","year":"","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L. Nature, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease.,, , 349,, 704-706,(1991)","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.1997.01830150090013","volume":"54","author":"Bergem A.L.","year":"","unstructured":"Bergem AL, Engedal K, Kringlen E. Arch Gen Psychiatry, The role of heredity in\u00a0late-onset\u00a0Alzheimer disease\u00a0and vascular dementia. A twin study.,, , 54,, 264-270,(1997)","journal-title":"Arch Gen Psychiatry"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archneur.63.9.1307","volume":"63","author":"Brickell K.L.","year":"","unstructured":"Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V. Arch Neurol, Early-onset\u00a0Alzheimer disease\u00a0in families with\u00a0late-onset\u00a0Alzheimer disease: a potential important subtype of familial\u00a0Alzheimer disease.,, , 63,, 1307-1311,(2006)","journal-title":"Arch Neurol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-160091","volume":"56","author":"Louwersheimer E.","year":"","unstructured":"Louwersheimer E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, Sistermans EA, Rozemuller AJ. J Alzheimers Dis, Rare\u00a0genetic\u00a0variant in SORL1 may increase penetrance of\u00a0Alzheimer\u2019s\u00a0Disease\u00a0in a\u00a0family\u00a0with several generations of APOE-\u025b4 homozygosity.,, , 56,, 63-74,(2017)","journal-title":"J Alzheimers Dis"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"Rogaev E.I.","year":"","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y. Nature, Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene.,, , 376,, 775-778,(1995)","journal-title":"Nature"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"12731","DOI":"10.1073\/pnas.1713605114","volume":"114","author":"Zhou R.","year":"","unstructured":"Zhou R, Yang G, Shi Y. Proc Natl Acad Sci USA, Dominant negative effect of the loss-of-function \u03b3-secretase mutants on the wild-type enzyme through hetero oligomerization.,, , 114,, 12731-12736,(2017)","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"Jankowsky J.L.","year":"","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA. Hum Mol Genet, Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.,, , 13,, 159-170,(2004)","journal-title":"Hum Mol Genet"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-179007","volume":"61","author":"Robinson M.","year":"","unstructured":"Robinson M, Lee BY, Hanes FT. J Alzheimers Dis, Recent progress in Alzheimer\u2019s disease research, Part 2: Genetics and epidemiology.,, , 61,, 459-,(2018)","journal-title":"J Alzheimers Dis"},{"key":"ref=9","author":"","unstructured":", . 1000 Genomes, a deep catalog of human genetic variation  http:\/\/phase3browser.1000genomes.org\/Homo_sapiens\/Variation\/Explore?db=core;r=14:73672678-73673678;v=rs17125721vdb=variation;vf=8537265,, , on May 31, 2018),"},{"key":"ref=10","first-page":"3071","volume":"29","author":"Gantier R.","year":"","unstructured":"Gantier R, Dumanchin C, Campion D, Loutelier C, Lange C, Gagnon J. Neuroreport, The L392V mutation of presenilin 1 associated with autosomal dominant early-onset Alzheimer\u2019s disease alters the secondary structure of the hydrophilic loop.,, , 29,, 3071-3074,(1999)","journal-title":"Neuroreport"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ana.410440624","volume":"44","author":"Aldudo J.","year":"","unstructured":"Aldudo J, Bullido MJ, Frank A, Valdivieso F. Ann Neurol, Missense mutation E318G of the presenilin-1 gene appears to be a nonpathogenic polymorphism.,, , 44,, 985-986,(1998)","journal-title":"Ann Neurol"},{"key":"ref=12","first-page":"65","volume":"7","author":"Helisalmi S.","year":"","unstructured":"Helisalmi S, Hiltunen M, Mannermaa A, Koivisto AM, Lehtovirta M, Alafuzoff I. Neurosci Lett, Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer\u2019s disease?,, , 7,, 65-68,(2000)","journal-title":"Neurosci Lett"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8","volume":"103","author":"Arango D.","year":"","unstructured":"Arango D, Cruts M, Torres O, Backhovens H, Serrano ML, Villareal E. Am J Med Genet, Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.,, , 103,, 138-143,(2001)","journal-title":"Am J Med Genet"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2003.12.052","volume":"357","author":"Zekanowski C.","year":"","unstructured":"Zekanowski C, Pep\u0142o\u0144ska B, Styczy\u0144ska M, Religa D, Pfeffer A, Czyzewski K. Neurosci Lett, The E318G substitution in PSEN1 gene is not connected with Alzheimer\u2019s disease in a large Polish cohort.,, , 357,, 167-170,(2004)","journal-title":"Neurosci Lett"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s004150050603","volume":"247","author":"Dermaut B.","year":"","unstructured":"Dermaut B, Cruts M, Backhovens H, Lubke U, Van Everbroeck B, Sciot R. J Neurol, Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion.,, , 247,, 364-368,(2000)","journal-title":"J Neurol"},{"key":"ref=16","first-page":"3009","volume":"16","author":"Berezovska O.","year":"","unstructured":"Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, Bacskai BJ. J Neurosci, Familial Alzheimer\u2019s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.,, , 16,, 3009-3017,(2005)","journal-title":"J Neurosci"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"e1003685","DOI":"10.1371\/journal.pgen.1003685","volume":"9","author":"Benitez B.A.","year":"","unstructured":"Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D. PLoS Genet, The PSEN1, p.E318G variant increases the risk of Alzheimer\u2019s disease in APOE-\u03b54 carriers.,, , 9,, e1003685-,(2013)","journal-title":"PLoS Genet"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12864-016-2786-z","volume":"17","author":"Hippen A.A.","year":"","unstructured":"Hippen AA, Ebbert MT, Norton MC, Tschanz JT, Munger RG, Corcoran CD. BMC Genomics, Presenilin E318G variant and Alzheimer\u2019s disease risk: the Cache County study.,, , 17,, 438-,(2016)","journal-title":"BMC Genomics"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.neurobiolaging.2006.07.003","volume":"28","author":"Albani D.","year":"","unstructured":"Albani D, Roiter I, Artuso V, Batelli S, Prato F, Pesaresi M. Neurobiol Aging, Presenilin-1 mutation E318G and familial Alzheimer\u2019s disease in the Italian population.,, , 28,, 1682-1688,(2007)","journal-title":"Neurobiol Aging"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"McKhann G.","year":"","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Neurology, Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.,, , 34,, 939-944,(1984)","journal-title":"Neurology"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"Dubois B.","year":"","unstructured":"Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S. Alzheimers Dement, Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria. Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer\u2019s Association on \u201cThe Preclinical State of AD\u201d; July 23, 2015; Washington DC, USA.,, , 12,, 292-323,(2016)","journal-title":"Alzheimers Dement"},{"key":"ref=22","first-page":"689","volume":"24","author":"Cockrell J.R.","year":"","unstructured":"Cockrell JR, Folstein MF. Psychopharmacology, Mini Mental State Examination (MMSE).,, , 24,, 689-692,(1988)","journal-title":"Psychopharmacology"},{"key":"ref=23","first-page":"2386","volume":"18","author":"Crum R.M.","year":"","unstructured":"Crum RM, Anthony JC, Bassett SS, Folstein MF. JAMA, Population-based norms for the mini-mental state examination by age and educational level.,, , 18,, 2386-2391,(1993)","journal-title":"JAMA"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/prca.200900166","volume":"4","author":"Albertini V.","year":"","unstructured":"Albertini V, Bruno A, Paterlini A, Lista S, Benussi L, Cereda C. Proteomics Clin Appl, Optimization protocol for amyloid-beta peptides detection in human cerebrospinal fluid using SELDI TOF MS.,, , 4,, 352-357,(2010)","journal-title":"Proteomics Clin Appl"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-150179","volume":"47","author":"Catania M.","year":"","unstructured":"Catania M, Di Fede G, Tonoli E, Benussi L, Pasquali C, Giaccone G. J Alzheimers Dis, Mirror image of the amyloid-\u03b2 species in cerebrospinal fluid and cerebral amyloid in Alzheimer\u2019s disease.,, , 47,, 877-881,(2015)","journal-title":"J Alzheimers Dis"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2009-1142","volume":"18","author":"Ghidoni R.","year":"","unstructured":"Ghidoni R, Albertini V, Squitti R, Paterlini A, Bruno A, Bernardini S. J Alzheimers Dis, Novel T719P AbetaPP mutation unbalances the relative proportion of amyloid-beta peptides.,, , 18,, 295-303,(2009)","journal-title":"J Alzheimers Dis"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-5-2","volume":"5","author":"Portelius E.","year":"","unstructured":"Portelius E, Andreasson U, Ringman JM, Buerger K, Daborg J, Buchhave P. Mol Neurodegener, Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer\u2019s disease.,, , 5,, 2-,(2010)","journal-title":"Mol Neurodegener"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/mmr.2012.774","volume":"5","author":"Portelius E.","year":"","unstructured":"Portelius E, Fortea J, Molinuevo JL, Gustavsson MK, Andreasson U, Sanchez-Valle R. Mol Med Rep, The amyloid-\u03b2 isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer\u2019s disease.,, , 5,, 1111-1115,(2012)","journal-title":"Mol Med Rep"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","volume":"39","author":"Sala Frigerio C.","year":"","unstructured":"Sala Frigerio C, De Strooper B. Annu Rev Neurosci, Alzheimer\u2019s disease mechanisms and emerging roads to novel therapeutics.,, , 39,, 57-79,(2016)","journal-title":"Annu Rev Neurosci"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0197-4580(01)00254-8","volume":"23","author":"Laws S.M.","year":"","unstructured":"Laws SM, Clarnette RM, Taddei K, Martins G, Paton A, Almeida OP. Neurobiol Aging, Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment.,, , 23,, 55-58,(2002)","journal-title":"Neurobiol Aging"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T09:40:52Z","timestamp":1560850852000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166833\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205015666181031150345","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}